Eastwood Bio-Medical Canada Inc
XTSX:EBM

Watchlist Manager
Eastwood Bio-Medical Canada Inc Logo
Eastwood Bio-Medical Canada Inc
XTSX:EBM
Watchlist
Price: 0.74 CAD
Market Cap: 51m CAD

Intrinsic Value

The intrinsic value of one EBM stock under the Base Case scenario is 0.03 CAD. Compared to the current market price of 0.74 CAD, Eastwood Bio-Medical Canada Inc is Overvalued by 96%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EBM Intrinsic Value
0.03 CAD
Overvaluation 96%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Eastwood Bio-Medical Canada Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about EBM?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is EBM valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Eastwood Bio-Medical Canada Inc.

Explain Valuation
Compare EBM to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EBM?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Eastwood Bio-Medical Canada Inc

Current Assets 31.1k
Cash & Short-Term Investments 22k
Receivables 8.3k
Other Current Assets 800
Non-Current Assets 185.7k
PP&E 185.7k
Current Liabilities 1.8m
Accounts Payable 79k
Short-Term Debt 71.3k
Other Current Liabilities 1.6m
Efficiency

Free Cash Flow Analysis
Eastwood Bio-Medical Canada Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Eastwood Bio-Medical Canada Inc

Revenue
594.6k CAD
Cost of Revenue
-214.6k CAD
Gross Profit
380k CAD
Operating Expenses
-779.7k CAD
Operating Income
-399.7k CAD
Other Expenses
-12.1k CAD
Net Income
-411.8k CAD
Fundamental Scores

EBM Profitability Score
Profitability Due Diligence

Eastwood Bio-Medical Canada Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
Exceptional Gross Margin
Strong 3Y Average Gross Margin
33/100
Profitability
Score

Eastwood Bio-Medical Canada Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

EBM Solvency Score
Solvency Due Diligence

Eastwood Bio-Medical Canada Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Long-Term Solvency
Short-Term Solvency
31/100
Solvency
Score

Eastwood Bio-Medical Canada Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EBM Price Targets Summary
Eastwood Bio-Medical Canada Inc

There are no price targets for EBM.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Eastwood Bio-Medical Canada Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for EBM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one EBM stock?

The intrinsic value of one EBM stock under the Base Case scenario is 0.03 CAD.

Is EBM stock undervalued or overvalued?

Compared to the current market price of 0.74 CAD, Eastwood Bio-Medical Canada Inc is Overvalued by 96%.

Back to Top